Compare URBN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URBN | XENE |
|---|---|---|
| Founded | 1970 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.2B |
| IPO Year | 1995 | 2014 |
| Metric | URBN | XENE |
|---|---|---|
| Price | $73.71 | $66.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $86.91 | $68.55 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $6,165,376,000.00 | $311,000.00 |
| Revenue This Year | $10.67 | N/A |
| Revenue Next Year | $7.01 | $2,496.48 |
| P/E Ratio | $56.74 | ★ N/A |
| Revenue Growth | ★ 11.07 | N/A |
| 52 Week Low | $59.54 | $30.00 |
| 52 Week High | $84.35 | $72.66 |
| Indicator | URBN | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 53.91 | 62.08 |
| Support Level | $66.22 | $52.40 |
| Resistance Level | $73.72 | $72.66 |
| Average True Range (ATR) | 2.54 | 2.75 |
| MACD | 0.48 | -0.19 |
| Stochastic Oscillator | 66.98 | 52.37 |
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.